Schedule 13G ownership disclosure
SANGAMO BIOSCIENCES INC
Security class unavailable · CUSIP: 800677106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,488,504
- Percent of class
- 7.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-018542
- Form type
- SC 13G
- Filer
- SANGAMO THERAPEUTICS, INC
- CIK
- CIK 1001233
- Filed
- Feb 12, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership